Short interest in Barinthus Biotherapeutics PLC (NASDAQ:BRNS) decreased during the last reporting period, falling from 25.37K to 13.61K. This put 0.06% of the company's publicly available shares short.

Short interest for Barinthus Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of Barinthus Biotherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 39.37K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.